Clofarabine Salvage Therapy in Patients With Relapsed or Refractory Acute Myeloid Leukemia (AML)

NCT01295307 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

86

Enrollment

OTHER

Sponsor class

Conditions

Acute Myeloid Leukemia

Interventions

DRUG: Clofarabine

Sponsor

Technische Universität Dresden

Collaborators

[object Object]